Sponsor Pipeline

Aveta Biomics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07667296 APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma Head and Neck Cancer Not Yet Recruiting
Phase 2
NCT05312710 Safety and Efficacy of APG-157 in Head and Neck Cancer Head and Neck Cancer Active, Not Recruiting
Phase 1/2
NCT06011109 Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab Glioma Recruiting
Disease Areas
Head & Neck Cancer (2) Glioblastoma (1) Glioma (1)
Get alerts when Aveta Biomics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free